We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Hypertension and Diabetes Initiative - Improving Hypertension Control in Individuals With Diabetes

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00743808
First Posted: August 29, 2008
Last Update Posted: December 2, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Advocate Medical Group
Baystate Health
William Beaumont Hospitals
Columbia Park Medical Group
Humboldt Del Norte Independent Practice Association
Metropolitan Health
Park Nicollet Clinic
PeaceHealth Medical Group
Sanford Clinic
TriHealth Inc.
University Hospitals Medical Practices
Warren Clinic
Novartis
Information provided by (Responsible Party):
HealthPartners Institute
June 9, 2008
August 29, 2008
December 2, 2015
December 2006
May 2008   (Final data collection date for primary outcome measure)
Systolic blood pressure [ Time Frame: 1 year ]
Same as current
Complete list of historical versions of study NCT00743808 on ClinicalTrials.gov Archive Site
Measure changes in action taken related to improving blood pressure management as percent of providers reporting changing (initiating or adjusting) blood pressure medication [ Time Frame: 1 year ]
Same as current
Not Provided
Not Provided
 
Hypertension and Diabetes Initiative - Improving Hypertension Control in Individuals With Diabetes
Improving Hypertension Control in Individuals With Diabetes

Twelve health organizations from around the US were selected to participate in a chart review Hypertension and Diabetes Initiative with the goal of improving blood pressure control in persons with diabetes.

Hypothesis:

A three-phase quality improvement initiative facilitated and monitored through the International Diabetes Center (IDC) will result in improved population-mean systolic blood pressure in the aggregate data pool of patients from all 12 participating sites at geographically distinct health systems.

Phase 1 - Preparation: Each participating site begins to organize itself for the project. Baseline data will be collected and will be used to benchmark where each site is relative to blood pressure control/management of persons with diabetes prior to the implementation of the training programs.

Phase 2 - Implementation: Sites begin to address the gaps they have identified that affect blood pressure outcomes of patients with diabetes. IDC provides two on-site training programs for providers and support staff.

Phase 3 - Follow-up: IDC provides on-going support to each site via individual and collaborative conference calls and resources on the project Web site. Patient and visit data (audit form) will be collected six and 12 months after training. This data will be compared to the site's pre-training data.
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
Primary care clinic
Hypertension
Other: quality improvement
3-phase quality improvement intervention
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
11510
September 2010
May 2008   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • ICD-9 Code 250 (indicates type 1 or type 2 diabetes)
  • ICD- Code 648.0 (indicates pregnancy with type 1 or type 2 diabetes)
  • ICD-9 Code 357.2 or 362.0, indicating complications of diabetes.
  • A prescription for insulin or oral hypoglycemic agents
  • Include those 18-75 years

Exclusion Criteria:

  • Attend a dialysis unit (if the nephrologist is primary care manager)
  • Have gestational diabetes (ICD-9 Code 648.8)
  • Have a terminal illness (e.g., hospice patient)
  • Do not have a documented blood pressure within the past year (this is asked on the audit form)
Sexes Eligible for Study: All
18 Years to 75 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT00743808
03527-06-C
No
Not Provided
Not Provided
HealthPartners Institute
HealthPartners Institute
  • Advocate Medical Group
  • Baystate Health
  • William Beaumont Hospitals
  • Columbia Park Medical Group
  • Humboldt Del Norte Independent Practice Association
  • Metropolitan Health
  • Park Nicollet Clinic
  • PeaceHealth Medical Group
  • Sanford Clinic
  • TriHealth Inc.
  • University Hospitals Medical Practices
  • Warren Clinic
  • Novartis
Principal Investigator: Margaret A Powers, PhD International Diabetes Center - Park Nicollet Institute
Principal Investigator: Robert M Cuddihy, MD International Diabetes Center - Park Nicollet Institute
HealthPartners Institute
August 2013
To Top